Despite extensive research and novel treatments, conditions associated with deranged cardiac metabolism such as heart failure (HF) or ischemia are still associated with a substantial risk of arrhythmic sudden death. Cardiac injury from many causes is associated with altered metabolism and downregulation of the cardiac sodium channel (SCN5A). Recently, data demonstrated that the SCN5A was substantially and immediately modulated by pyridine nucleotides. Physiologically relevant elevations in intracellular NADH resulted in a rapid decrease in INa in both HEK cells and cardiomyocytes that was large enough to be clinically significant. The immediacy of the NADH effect on reducing INa and the lack of change in mRNA abundances under various experimental conditions suggested that the effect of NADH was post-transcriptional. Internally or externally applied NAD+ antagonized the downregulation of current seen with a rise of internal NADH. The finding that the balance of oxidized and reduced pyridine nucleotides regulates the Na+ current suggests that the metabolic state of myocytes may influence INa. The results identify a heretofore unknown regulation of cardiac Na+ channels that may help explain the link between metabolism and arrhythmic risk and may suggest that NAD+ could lessen arrhythmic risk resulting from reduced INa. This application proposes to extend these findings to better understand the mechanism whereby changes in pyridine nucleotides cause SCN5A regulation and to establish the relevance of these changes to arrhythmogenesis in myopathy models. Specific Objectives.
Specific aim 1 : To determine the mechanism by which NADH acts on the Na+ channel to mediate downregulation of INa. These experiments will differentiate between two leading hypotheses for how NADH mediates its effects on the Na+ channel, either by direct action on the channel complex or by causing channel isolation from the sarcolemma. Insight into Na+ channel regulation may allow mitigation of arrhythmic risk associated with low INa states.
Specific aim 2 : To determine which proteins are modified in the mitochondrial electron transport chain (ETC) by NADH and NAD+. As we have recently shown, the effects of NADH and NAD+ on mitochondrial ROS production are kinase dependent. Our preliminary data show that NADH activates mitochondrial ROS production via PKC, and NAD+ prevents this via PKA. Using ETC inhibitors and activators, we localized the source of ROS to either complexes I or III.17 We propose to use proteomic techniques to establish if PKA and PKC phosphorylate these complexes and whether that phosphorylation results in alteration of mitochondrial respiration, complex activity, or ROS production to better understand the mechanisms regulating mitochondrial ROS production.
Specific aim 3 : To determine whether NAD+ can mitigate reduced INa in ischemic and nonischemic cardiomyopathy models. Our preliminary data suggests that NAD+ may serve to mitigate arrhythmic risk in states where INa is decreased. We will test this hypothesis in two cardiomyopathy models as preliminary data for NAD+ use in humans.

Public Health Relevance

Despite extensive research and novel treatments, conditions associated with deranged cardiac metabolism such as heart failure or ischemia are still associated with a substantial risk of sudden death. The finding that the balance of oxidized and reduced pyridine nucleotides regulates the sodium current suggests that the heart metabolic state influences sodium current. Our results identify a heretofore unknown regulation of cardiac sodium channels that may help explain the link between metabolism and sudden death and may suggest that NAD+ could lessen death risk resulting from reduced sodium current.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL106592-04
Application #
8733197
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Wang, Lan-Hsiang
Project Start
2011-07-15
Project End
2015-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Rhode Island Hospital
Department
Type
DUNS #
City
Providence
State
RI
Country
United States
Zip Code
02903
Xie, An; Zhou, Anyu; Liu, Hong et al. (2018) Mitochondrial Ca2+ flux modulates spontaneous electrical activity in ventricular cardiomyocytes. PLoS One 13:e0200448
Noyes, Adam M; Zhou, Anyu; Gao, Ge et al. (2017) Abnormal sodium channel mRNA splicing in hypertrophic cardiomyopathy. Int J Cardiol 249:282-286
Liu, Man; Shi, Guangbin; Yang, Kai-Chien et al. (2017) Role of protein kinase C in metabolic regulation of the cardiac Na+ channel. Heart Rhythm 14:440-447
Kim, Tae Yun; Terentyeva, Radmila; Roder, Karim H F et al. (2017) SK channel enhancers attenuate Ca2+-dependent arrhythmia in hypertrophic hearts by regulating mito-ROS-dependent oxidation and activity of RyR. Cardiovasc Res 113:343-353
Jiang, Ning; Zhou, Anyu; Prasad, Bharati et al. (2016) Obstructive Sleep Apnea and Circulating Potassium Channel Levels. J Am Heart Assoc 5:
Liu, M; Yang, K-C; Dudley Jr, S C (2016) Cardiac Sodium Channel Mutations: Why so Many Phenotypes? Curr Top Membr 78:513-59
Jeong, Euy-Myoung; Chung, Jaehoon; Liu, Hong et al. (2016) Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction. J Am Heart Assoc 5:
Jeong, Euy-Myoung; Dudley Jr, Samuel C (2015) Diastolic dysfunction. Circ J 79:470-7
Liu, Man; Dudley Jr, Samuel C (2015) Role for the Unfolded Protein Response in Heart Disease and Cardiac Arrhythmias. Int J Mol Sci 17:
Yang, Kai-Chien; Kyle, John W; Makielski, Jonathan C et al. (2015) Mechanisms of sudden cardiac death: oxidants and metabolism. Circ Res 116:1937-55

Showing the most recent 10 out of 31 publications